Pangaea Oncology, S.A. (BME:PANG)

Spain · Delayed Price · Currency is EUR

1.580

+0.030 (1.94%)

May 29, 2026, 4:00 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	16.73M	16.79M	9.95M	6.68M	6.71M
Biotechnology Growth	-0.32%	68.64%	49.12%	-0.48%	8.61%
Total	16.73M	16.79M	9.95M	6.68M	6.71M
Total Growth	-0.32%	68.64%	49.12%	-0.48%	8.61%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Spain	11.46M	12.18M	7.02M	3.81M	3.22M
Spain Growth	-5.90%	73.64%	84.22%	18.14%	-4.35%
Other Countries of The European Union	223.06K	104.10K	219.59K	100.66K	689.76K
Other Countries of The European Union Growth	114.28%	-52.60%	118.15%	-85.41%	88.89%
Other	2.84M	1.98M	763.25K	458.91K	690.01K
Other Growth	43.06%	159.93%	66.32%	-33.49%	-
Total	14.52M	14.27M	8.00M	4.37M	4.60M
Total Growth	1.78%	78.41%	83.12%	-5.11%	12.29%

Source: S&P Global Market Intelligence.